7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Valvular Heart Disease
The heart's valves play a crucial role in maintaining proper blood flow, but when these valves become diseased, it can lead to significant cardiovascular issues. Valvular heart disease can manifest in several forms, including mitral valve prolapse, aortic stenosis, and tricuspid regurgitation. These conditions can lead to inefficient heart pumping, causing symptoms like dizziness, chest pain, or fluid retention. Risk factors include previous heart infections, aging, and genetic predisposition. The treatment for valvular heart disease often includes lifestyle adjustments, medications to manage symptoms, and in more advanced cases, surgical procedures such as valve repair or replacement. Monitoring and early intervention are essential to improve long-term outcomes and prevent complications like heart failure.
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Steve Cohen
Medvesta Hypnosis Healthcare, NSA Illinois, United States
Ruth Rasmussen
Liberty University, United States
Franz Porzsolt
Private Research Institute Clinical Economics, GermanySubmit your abstract Today
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Implantation of permanent cardiac pacemakers with right-sided access in collaboration with a vascular surgeon: pro et contra
Davor Horvat, General Hospital, , Croatia (Hrvatska)
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : MrgD as a Novel Modeling and Treatment Target for Pulmonary Hypertension
Panpan Hao, Department of Cardiology, Qilu Hospital, Shandong University, Jinan, Shandong, China